These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12663499)

  • 1. Antitumor and anticarcinogenic actions of Cpd 5: a new class of protein phosphatase inhibitor.
    Kar S; Wang M; Wilcox CS; Carr BI
    Carcinogenesis; 2003 Mar; 24(3):411-6. PubMed ID: 12663499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K vitamins, PTP antagonism, and cell growth arrest.
    Carr BI; Wang Z; Kar S
    J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z; Wang M; Carr BI
    J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK.
    Kar S; Wang M; Ham SW; Carr BI
    Biochem Pharmacol; 2006 Nov; 72(10):1217-27. PubMed ID: 16930563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway.
    Wang Z; Wang M; Carr BI
    J Cell Physiol; 2005 Jun; 203(3):510-9. PubMed ID: 15534860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo.
    Kar S; Wang M; Yao W; Michejda CJ; Carr BI
    Mol Cancer Ther; 2006 Jun; 5(6):1511-9. PubMed ID: 16818510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compound.
    Kar S; Wang M; Rosi KS; Wilcox CS; Carr BI
    Carcinogenesis; 2004 Dec; 25(12):2345-51. PubMed ID: 15319298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of novel vitamin K analog induced growth inhibition in human hepatoma cell line.
    Osada S; Carr BI
    J Hepatol; 2001 May; 34(5):676-82. PubMed ID: 11434613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK.
    Kar S; Wang M; Ham SW; Carr BI
    Cancer Biol Ther; 2006 Oct; 5(10):1340-7. PubMed ID: 16969075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR-independent activation of ERK1/2 mediates growth inhibition by a PTPase antagonizing K-vitamin analog.
    Kar S; Adachi T; Carr BI
    J Cell Physiol; 2002 Mar; 190(3):356-64. PubMed ID: 11857451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition and protein tyrosine phosphorylation in MCF 7 breast cancer cells by a novel K vitamin.
    Kar S; Carr BI
    J Cell Physiol; 2000 Dec; 185(3):386-93. PubMed ID: 11056008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient and sustained ERK phosphorylation and nuclear translocation in growth control.
    Adachi T; Kar S; Wang M; Carr BI
    J Cell Physiol; 2002 Aug; 192(2):151-9. PubMed ID: 12115721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z; Ge L; Wang M; Carr BI
    J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins.
    Osada S; Osada K; Carr BI
    J Mol Biol; 2001 Dec; 314(4):765-72. PubMed ID: 11733995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell growth inhibition by a novel vitamin K is associated with induction of protein tyrosine phosphorylation.
    Ni R; Nishikawa Y; Carr BI
    J Biol Chem; 1998 Apr; 273(16):9906-11. PubMed ID: 9545333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel hydroxyl naphthoquinones with potent Cdc25 antagonizing and growth inhibitory properties.
    Peyregne VP; Kar S; Ham SW; Wang M; Wang Z; Carr BI
    Mol Cancer Ther; 2005 Apr; 4(4):595-602. PubMed ID: 15827333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5.
    Wang Z; Ge L; Wang M; Carr BI
    Hepatology; 2007 Dec; 46(6):2003-13. PubMed ID: 18046719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdc25 inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue.
    Tamura K; Southwick EC; Kerns J; Rosi K; Carr BI; Wilcox C; Lazo JS
    Cancer Res; 2000 Mar; 60(5):1317-25. PubMed ID: 10728693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdc25A and ERK interaction: EGFR-independent ERK activation by a protein phosphatase Cdc25A inhibitor, compound 5.
    Wang Z; Zhang B; Wang M; Carr BI
    J Cell Physiol; 2005 Aug; 204(2):437-44. PubMed ID: 15672448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis.
    Kar S; Wang M; Carr BI
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):831-40. PubMed ID: 18246350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.